You are here

(ARLINGTON HEIGHTS, IL - March 16, 2017) - The American College of Allergy, Asthma and Immunology (ACAAI) and the American Academy of Allergy, Asthma and Immunology (AAAAI) are gravely concerned about the impact President Trump's proposed budget, released earlier today, will have on the future of medical research. We call on Congress to reject the proposed cuts to the National Institutes of Health (NIH) and instead, build on the commitment made last year to begin increasing spending for medical research.

The President's budget blueprint recommends significant, largely unspecified, cuts to the budget of the NIH. In total, the proposed reduction would amount to approximately 20 percent of the NIH's entire budget.

ACAAI president Stephen A. Tilles, MD and AAAAI president David B. Peden, MD said the following upon learning of the proposed cuts: "Although the budget blueprint released by President Trump earlier today is short on specifics, it is hard to imagine how cuts of this magnitude could be accomplished without doing serious harm to the core mission of the NIH – medical research. Together, we call upon Congress to reject any cuts to the NIH that would decrease the NIH's ability to conduct life-saving medical research and training."

NIH, and in particular the National Institute of Allergy and Infectious Diseases (NIAID), the National Heart Lung and Blood Institute (NHLBI) and the National Institute of Environmental Health Sciences (NIEHS) are providing vital funding for medical research that could lead to life-improving treatments for individuals suffering from allergies, asthma, immunologic disorders and infectious diseases (including HIV/AIDS, emerging and reemerging infectious diseases).

Each year, billions of dollars are spent treating the causes and symptoms of food, drug and skin allergy, immunodeficiency, and asthma. Through the work of NIAID, NHLBI and NIEHS and the research they are funding, we have the opportunity to identify and develop life-saving and life-improving treatments for these widespread chronic conditions.

This past October, NIAID researchers announced promising results from an NIH sponsored clinical trial on the efficacy and value of an intervention for treating children and young adults with peanut allergies. This January a NIAID sponsored expert panel issued clinical guidelines to help health care providers give parents and caregivers important information on early introduction of peanut-containing foods to infants to prevent the development of peanut allergy. These are the type of results the American people can expect from supporting NIH (NIAID, NHLBI and NIEHS) and their medical research mission.

ACAAI and AAAAI call on Congress to continue its bi-partisan support for the NIH and the NIAID, NHLBI and NIEHS as it completes the 2017 appropriations process and embarks on enacting appropriations bills for fiscal year 2018. 

About ACAAI

The ACAAI is a professional medical organization of more than 6,000 allergists-immunologists and allied health professionals, headquartered in Arlington Heights, Ill. The College fosters a culture of collaboration and congeniality in which its members work together and with others toward the common goals of patient care, education, advocacy and research. ACAAI allergists are board-certified physicians trained to diagnose allergies and asthma, administer immunotherapy, and provide patients with the best treatment outcomes. For more information and to find relief, visit AllergyandAsthmaRelief.org. Join us on Facebook, Pinterest and Twitter.

Get relief from your allergies.

Sign up for expert tips delivered to your mailbox.